{"id":2988,"date":"2017-12-01T07:30:00","date_gmt":"2017-12-01T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/first-xps-installed-in-china\/"},"modified":"2017-12-01T07:30:00","modified_gmt":"2017-12-01T07:30:00","slug":"first-xps-installed-in-china","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/","title":{"rendered":"First XPS\u2122 installed in China"},"content":{"rendered":"
XVIVO Perfusion has installed the first XPS\u2122 in China. The purpose is to start an EVLP (Ex Vivo Lung Perfusion)-study at Shanghai Pulmonary Hospital. The study is designed to complement existing EVLP data, with Chinese data. \u00a0The company is planning to initiate an approval process of the XPS\u2122 with CFDA (China Food and Drug Administration). STEEN Solution\u2122 and Perfadex are already approved by CDFA.<\/strong><\/div>\n

China is currently the fastest growing lung transplant market in the world, with a 37% increase in lung transplants in 2016 (201 lung transplants performed). Due to the increased need for lung transplantation the number of clinics authorized to perform lung transplants has increased from 20 clinics in 2016 to 27 clinics in 2017. In parallel with the transplant centers growth, the organ donation system in China is also growing to meet this lifesaving demand. The current donor system is an OPO system, with the expectation to take advantage of increased utilization of marginal lungs for transplant.\u00a0 The end point of this collaboration is to reduce mortality on the waiting list. <\/span><\/p>\n

The Lung Transplantation program lead by Professor Jiang Gening will head the first EVLP- study in China that will investigate the effects of EVLP on Lung transplantation. The study design is an investigator initiated single center trial with the intention to add Chinese data to the existing EVLP data from North America and Europe. The company plans to initiate a registration process of the XPS\u2122 with the CFDA. In partnership with XVIVO Perfusion\u00b4s Distributor in China (Genext Ltd), we plan to\u00a0 scientifically support the Lung transplant clinic at Shanghai Pulmonary Hospital, the leading hospital in treatment of lung diseases in China. The hospital has over 1,000 beds and performed more than 10,000 thoracic surgery operations last year. With the addition of the XVIVO XPS\u2122 system the Shanghai Pulmonary Hospital fully expects to become the EVLP Center of Excellence in Asia.<\/span><\/p>\n

\u00a0\u201cWe are delighted that we delivered the first XPS to China with the intention of a clinical study. China has put a lot of effort in increasing the number of transplants performed, and it has from a low level resulted in rapid growth in the past three years. Considering the size of the population and the fast increase in the standard of living and healthcare, China is expected to become an important market for XVIVO in a not too distant future\u201d, says Magnus Nilsson, CEO of XVIVO Perfusion. <\/span><\/p>\n

December 1, 2017
<\/span>Gothenburg
Magnus Nilsson, CEO
XVIVO Perfusion AB (publ)<\/p>\n

\n

For further information please contact:<\/span><\/p>\n

Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com<\/span>
For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/span><\/p>\n

This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.\u00a0\u00a0The information was submitted for publication, through the agency of the contact person set out above, at 08:30 am CET on December 1, 2017.<\/span><\/p>\n

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion has installed the first XPS\u2122 in China. The purpose is to start an EVLP (Ex Vivo Lung Perfusion)-study…<\/p>\n","protected":false},"template":"","class_list":["post-2988","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn-ci"],"acf":[],"yoast_head":"\nFirst XPS\u2122 installed in China - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First XPS\u2122 installed in China - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion has installed the first XPS\u2122 in China. The purpose is to start an EVLP (Ex Vivo Lung Perfusion)-study...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-installed-in-china\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-installed-in-china\\\/\",\"name\":\"First XPS\u2122 installed in China - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2017-12-01T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-installed-in-china\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-installed-in-china\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-installed-in-china\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First XPS\u2122 installed in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First XPS\u2122 installed in China - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/","og_locale":"en_US","og_type":"article","og_title":"First XPS\u2122 installed in China - XVIVO","og_description":"XVIVO Perfusion has installed the first XPS\u2122 in China. The purpose is to start an EVLP (Ex Vivo Lung Perfusion)-study...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/","name":"First XPS\u2122 installed in China - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2017-12-01T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-installed-in-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"First XPS\u2122 installed in China"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}